Benzinga's Top Upgrades, Downgrades For May 19, 2020

Upgrades

• HC Wainwright & Co. changed the rating for BioNTech SE BNTX from Neutral to Buy. Interestingly, in the first quarter, BioNTech's EPS was ($0.26). The stock has a 52-week-high of $105.00 and a 52-week-low of $12.53. BioNTech's stock last closed at $60.17 per share.
• Roth Capital upgraded the stock for Allogene Therapeutics Inc ALLO from Neutral to Buy. For the first quarter, Allogene Therapeutics had an EPS of ($0.50), compared to year-ago quarter EPS of ($0.32). The stock has a 52-week-high of $48.87 and a 52-week-low of $17.43. Allogene Therapeutics's stock last closed at $48.34 per share.
• Piper Sandler changed the rating for Alteryx Inc AYX from Neutral to Overweight. For the first quarter, Alteryx had an EPS of ($0.10), compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $160.11 and a 52-week-low of $75.17. Alteryx's stock last closed at $128.92 per share.
• Credit Suisse changed the rating for Black Hills Corp BKH from Neutral to Outperform. For the first quarter, Black Hills had an EPS of $1.59, compared to year-ago quarter EPS of $1.73. The stock has a 52-week-high of $87.12 and a 52-week-low of $48.07. Black Hills's stock last closed at $59.30 per share.
• Bernstein changed the rating for The Hain Celestial Group Inc HAIN from Market Perform to Outperform. For the third quarter, Hain Celestial Group had an EPS of $0.28, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $31.92 and a 52-week-low of $17.94. Hain Celestial Group's stock last closed at $29.13 per share.
• RBC Capital upgraded the stock for Johnson Controls International PLC JCI from Underperform to Sector Perform. In the second quarter, Johnson Controls Intl showed an EPS of $0.42, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $44.82 and a 52-week-low of $22.77. Johnson Controls Intl's stock last closed at $29.53 per share.
• Morgan Stanley upgraded the stock for Parsley Energy Inc PE from Equal-Weight to Overweight. Parsley Energy earned $0.29 in the first quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $21.03 and a 52-week-low of $3.92. Parsley Energy's stock last closed at $9.59 per share.
• UBS changed the rating for Aptiv PLC APTV from Neutral to Buy. In the first quarter, Aptiv showed an EPS of $0.68, compared to $1.05 from the year-ago quarter. The stock has a 52-week-high of $99.04 and a 52-week-low of $29.22. Aptiv's stock last closed at $70.23 per share.
• For Mantech International Corp MANT, Wells Fargo upgraded the stock from Equal-Weight to Overweight. In the first quarter, Mantech Intl showed an EPS of $0.81, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $93.99 and a 52-week-low of $55.25. Mantech Intl's stock last closed at $71.28 per share.
• For Wyndham Destinations Inc WYND, JP Morgan upgraded the stock from Neutral to Overweight. Wyndham Destinations earned ($0.98) in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $53.13 and a 52-week-low of $13.74. Wyndham Destinations's stock last closed at $27.69 per share.

Downgrades

• JP Morgan changed the rating for Mallinckrodt PLC MNK from Neutral to Underweight. For the first quarter, Mallinckrodt had an EPS of $1.64, compared to year-ago quarter EPS of $1.94. The stock has a 52-week-high of $15.35 and a 52-week-low of $1.00. Mallinckrodt's stock last closed at $3.34 per share.
• Morgan Stanley downgraded the stock for Marathon Oil Corp MRO from Equal-Weight to Underweight. Marathon Oil earned ($0.16) in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $16.02 and a 52-week-low of $3.02. Marathon Oil's stock last closed at $6.08 per share.
• JP Morgan changed the rating for TherapeuticsMD Inc TXMD from Overweight to Neutral. In the first quarter, TherapeuticsMD showed an EPS of ($0.21), compared to ($0.16) from the year-ago quarter. The stock has a 52-week-high of $4.32 and a 52-week-low of $0.85. TherapeuticsMD's stock last closed at $1.19 per share.
• For PBF Energy Inc PBF, Barclays downgraded the stock from Overweight to Underweight. In the first quarter, PBF Energy showed an EPS of ($1.19), compared to ($1.18) from the year-ago quarter. The stock has a 52-week-high of $34.91 and a 52-week-low of $5.19. PBF Energy's stock last closed at $10.92 per share.
• Jefferies downgraded the stock for Expedia Group Inc EXPE from Buy to Hold. In the fourth quarter, Expedia Group showed an EPS of $1.24, compared to $1.24 from the year-ago quarter. The stock has a 52-week-high of $144.00 and a 52-week-low of $40.76. Expedia Group's stock last closed at $79.19 per share.

Initiations

• Seaport Global initiated coverage on Lockheed Martin Corp LMT with a Buy rating. The price target for Lockheed Martin is set at $435.00. In the first quarter, Lockheed Martin showed an EPS of $6.08, compared to $5.99 from the year-ago quarter. The stock has a 52-week-high of $442.53 and a 52-week-low of $266.11. Lockheed Martin's stock last closed at $376.95 per share.
• With a rating of Outperform, Raymond James initiated coverage on Kadmon Holdings Inc KDMN. The price target is set at $7.00 for Kadmon Holdings. For the first quarter, Kadmon Holdings had an EPS of ($0.19), compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $5.50 and a 52-week-low of $1.63. Kadmon Holdings's stock last closed at $4.41 per share.
• With a rating of Outperform, Oppenheimer initiated coverage on Moody's Corporation MCO. The price target is set at $290.00 for Moody's. Moody's earned $2.73 in the first quarter, compared to $2.07 in the year-ago quarter. The stock has a 52-week-high of $287.25 and a 52-week-low of $164.19. Moody's's stock last closed at $259.76 per share.
• With a rating of Overweight, Cantor Fitzgerald initiated coverage on RAPT Therapeutics Inc RAPT. The price target is set at $37.00 for RAPT Therapeutics. Interestingly, in the fourth quarter, RAPT Therapeutics's EPS was ($0.87). The stock has a 52-week-high of $51.21 and a 52-week-low of $10.52. RAPT Therapeutics's stock last closed at $16.05 per share.
• Oppenheimer initiated coverage on S&P Global Inc SPGI with an Outperform rating. The price target for S&P Global is set at $340.00. S&P Global earned $2.73 in the first quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of $316.25 and a 52-week-low of $186.06. S&P Global's stock last closed at $311.54 per share.
• Needham initiated coverage on OneSpan Inc OSPN with a Buy rating. The price target for OneSpan is set at $24.00. In the first quarter, OneSpan showed an EPS of $0.08, compared to ($0.07) from the year-ago quarter. The stock has a 52-week-high of $20.53 and a 52-week-low of $10.88. OneSpan's stock last closed at $18.22 per share.
• BTIG initiated coverage on Beyond Meat Inc BYND with a Buy rating. The price target for Beyond Meat is set at $173.00. Beyond Meat earned $0.03 in the first quarter, compared to ($0.14) in the year-ago quarter. The stock has a 52-week-high of $239.71 and a 52-week-low of $48.18. Beyond Meat's stock last closed at $130.03 per share.